Latest filing published 28 May 2025 for LENSAR, Inc.. Read the official filing
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Gary M. Winer (board member) discloses dealings in 2 companies, chiefly LENSAR, Inc. and HCW Biologics Inc. The record holds 24 filings, for trades running from 25 May 2022 to 23 May 2025.
Purchases make up the whole of the open-market record (20 purchases, €102k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants. 2025 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €1,996. Of 20 purchases, 8 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 28 May 2025, reports a share grant in LENSAR, Inc. The last purchase on record was published on 20 May 2025, which is 516 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations